# Flu+CPM+rATG Conditioning Regimes for Unrelated Bone Marrow Transplantation (UBMT)(or Mobilized Peripheral Blood)in Severe Aplastic Anemia (SAA)

> **NCT00737685** · PHASE2 · UNKNOWN · sponsor: **The Korean Society of Pediatric Hematology Oncology** · enrollment: 30 (estimated)

## Conditions studied

- Anemia, Aplastic

## Interventions

- **DRUG:** cyclophosphamide, fludarabine , thymoglobulin

## Key facts

- **NCT ID:** NCT00737685
- **Lead sponsor:** The Korean Society of Pediatric Hematology Oncology
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-01
- **Primary completion:** 2012-08
- **Final completion:** 2012-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2012-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00737685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00737685, "Flu+CPM+rATG Conditioning Regimes for Unrelated Bone Marrow Transplantation (UBMT)(or Mobilized Peripheral Blood)in Severe Aplastic Anemia (SAA)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00737685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*